These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 34599587

  • 1. Characteristics of Growth in Children With Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency During Adrenarche and Beyond.
    Troger T, Sommer G, Lang-Muritano M, Konrad D, Kuhlmann B, Zumsteg U, Flück CE.
    J Clin Endocrinol Metab; 2022 Jan 18; 107(2):e487-e499. PubMed ID: 34599587
    [Abstract] [Full Text] [Related]

  • 2. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W, Schwarz HP.
    Horm Res Paediatr; 2011 Jan 18; 75(4):264-8. PubMed ID: 21196707
    [Abstract] [Full Text] [Related]

  • 3. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
    Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H, MEWPE-CAH Study Group.
    Horm Res; 2001 Jan 18; 55(4):161-71. PubMed ID: 11598369
    [Abstract] [Full Text] [Related]

  • 4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Beier C, Dörr HG.
    Pediatrics; 2006 Jan 18; 117(1):e98-105. PubMed ID: 16396852
    [Abstract] [Full Text] [Related]

  • 5. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
    Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
    J Steroid Biochem Mol Biol; 2017 Jan 18; 165(Pt B):396-406. PubMed ID: 27544322
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
    J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
    [Abstract] [Full Text] [Related]

  • 7. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Öhl L, Rauh M, Schöfl C, Dörr HG.
    Horm Res Paediatr; 2011 Oct 25; 76(6):400-10. PubMed ID: 22123283
    [Abstract] [Full Text] [Related]

  • 8. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
    Hauffa BP, Winter A, Stolecke H.
    Klin Padiatr; 1997 Oct 25; 209(2):71-7. PubMed ID: 9113619
    [Abstract] [Full Text] [Related]

  • 9. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2007 May 25; 92(5):1635-9. PubMed ID: 17299071
    [Abstract] [Full Text] [Related]

  • 10. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
    Aycan Z, Ocal G, Berberoglu M, Cetinkaya E, Adiyaman P, Evliyaoglu O.
    J Pediatr Endocrinol Metab; 2006 Mar 25; 19(3):245-51. PubMed ID: 16607925
    [Abstract] [Full Text] [Related]

  • 11. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
    Bonfig W, Schmidt H, Schwarz HP.
    Horm Res Paediatr; 2011 Mar 25; 75(1):32-7. PubMed ID: 20714115
    [Abstract] [Full Text] [Related]

  • 12. Growth and Treatment in Congenital Adrenal Hyperplasia: An Observational Study from Diagnosis to Final Height.
    Gidlöf S, Hogling DE, Lönnberg H, Ritzén M, Lajic S, Nordenström A.
    Horm Res Paediatr; 2024 Mar 25; 97(5):445-455. PubMed ID: 38016434
    [Abstract] [Full Text] [Related]

  • 13. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
    J Pediatr; 2015 Mar 25; 166(3):743-50. PubMed ID: 25557963
    [Abstract] [Full Text] [Related]

  • 14. 'Exaggerated adrenarche' in children presenting with premature adrenarche.
    Likitmaskul S, Cowell CT, Donaghue K, Kreutzmann DJ, Howard NJ, Blades B, Silink M.
    Clin Endocrinol (Oxf); 1995 Mar 25; 42(3):265-72. PubMed ID: 7758231
    [Abstract] [Full Text] [Related]

  • 15. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
    Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
    Endocr Pract; 2017 May 25; 23(5):546-556. PubMed ID: 28225306
    [Abstract] [Full Text] [Related]

  • 16. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
    Horm Res; 1997 May 25; 47(1):17-22. PubMed ID: 9010713
    [Abstract] [Full Text] [Related]

  • 17. [Comparative study of prednisolone versus hydrocortisone acetate for treatment of patients with the classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Leite FM, Longui CA, Kochi C, Faria CD, Borghi M, Calliari LE, Monte O.
    Arq Bras Endocrinol Metabol; 2008 Feb 25; 52(1):101-8. PubMed ID: 18345402
    [Abstract] [Full Text] [Related]

  • 18. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood.
    Yu AC, Grant DB.
    Acta Paediatr; 1995 Aug 25; 84(8):899-903. PubMed ID: 7488814
    [Abstract] [Full Text] [Related]

  • 19. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
    Ahmed SEAM, Soliman AT, Ramadan MA, Elawwa A, Abugabal AMS, Emam MHA, De Sanctis V.
    Acta Biomed; 2019 Sep 06; 90(3):360-369. PubMed ID: 31580328
    [Abstract] [Full Text] [Related]

  • 20. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
    Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K.
    Clin Endocrinol (Oxf); 2019 Jul 06; 91(1):124-130. PubMed ID: 31070802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.